Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 63, Issue 3, Pages (March 2013)

Similar presentations


Presentation on theme: "Volume 63, Issue 3, Pages (March 2013)"— Presentation transcript:

1 Volume 63, Issue 3, Pages 462-472 (March 2013)
Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance  Jorg Oddens, Maurizio Brausi, Richard Sylvester, Aldo Bono, Cees van de Beek, George van Andel, Paolo Gontero, Wolfgang Hoeltl, Levent Turkeri, Sandrine Marreaud, Sandra Collette, Willem Oosterlinck  European Urology  Volume 63, Issue 3, Pages (March 2013) DOI: /j.eururo Copyright © 2012 European Association of Urology Terms and Conditions

2 Fig. 1 Consolidated Standards of Reporting Trials diagram. FD=full dose; ITT=intention to treat. European Urology  , DOI: ( /j.eururo ) Copyright © 2012 European Association of Urology Terms and Conditions

3 Fig. 2 Disease-free interval by treatment group. BCG=bacillus Calmette-Guérin; df=degrees of freedom; FD=full dose; O=observed number of events. European Urology  , DOI: ( /j.eururo ) Copyright © 2012 European Association of Urology Terms and Conditions

4 Fig. 3 Disease-free interval: one-third dose versus full dose. BCG=bacillus Calmette-Guérin; FD=full dose; O=observed number of events. European Urology  , DOI: ( /j.eururo ) Copyright © 2012 European Association of Urology Terms and Conditions

5 Fig. 4 Disease-free interval: 1 yr of maintenance versus 3 yr of maintenance. BCG=bacillus Calmette-Guérin; O=observed number of events. European Urology  , DOI: ( /j.eururo ) Copyright © 2012 European Association of Urology Terms and Conditions

6 Fig. 5 Disease-free interval: 1 yr of maintenance versus 3 yr of maintenance according to dose and risk group. HR=hazard ratio; CI=confidence interval; df=degrees of freedom. European Urology  , DOI: ( /j.eururo ) Copyright © 2012 European Association of Urology Terms and Conditions

7 Fig. 6 Time to progression by treatment group. BCG=bacillus Calmette-Guérin; df=degrees of freedom; FD=full dose; O=observed number of events. European Urology  , DOI: ( /j.eururo ) Copyright © 2012 European Association of Urology Terms and Conditions

8 Fig. 7 Duration of survival by treatment group. BCG=bacillus Calmette-Guérin; df=degrees of freedom; FD=full dose; O=observed number of events. European Urology  , DOI: ( /j.eururo ) Copyright © 2012 European Association of Urology Terms and Conditions


Download ppt "Volume 63, Issue 3, Pages (March 2013)"

Similar presentations


Ads by Google